詳細検索

詳細検索

お問い合わせ

Global Oncology Drugs Market 2026-2030

Global Oncology Drugs Market 2026-2030


Global Oncology Drugs Market 2026-2030 The global oncology drugs market is forecasted to grow by USD 201568.1 mn during 2025-2030, accelerating at a CAGR of 11.6% during the forecast period. The r... もっと見る

 

 

出版社
TechNavio
テクナビオ
出版年月
2026年8月10日
電子版価格
US$2,500
シングルユーザーライセンス
ライセンス・価格情報/注文方法はこちら
納期
2営業日程度
ページ数
316
言語
英語

英語原文をAIを使って翻訳しています


 

Summary

Global Oncology Drugs Market 2026-2030
The global oncology drugs market is forecasted to grow by USD 201568.1 mn during 2025-2030, accelerating at a CAGR of 11.6% during the forecast period. The report on the global oncology drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of malignancies and aging demographics, accelerated innovation in precision medicine and novel modalities, expanding access and strategic clinical combinations.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data. For further information on this report, please visit -

Technavio's global oncology drugs market is segmented as below:
By Therapy
• Targeted therapy
• Immunotherapy and hormonal therapy
• Chemotherapy
By Distribution Channel
• Hospital pharmacies
• Retail pharmacies
• Online pharmacies
By Form Factor
• Solid
• Injectable
• Liquid
By Indication
• Blood cancer
• Breast cancer
• Lung cancer
• Colorectal cancer
• Others
Geography
• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• UK
• Italy
• Spain
• The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)
This study identifies the precision medicine and biomarker-driven therapeutics as one of the prime reasons driving the global oncology drugs market growth during the next few years. Also, expansion of novel immunotherapy modalities and integration of ai in oncology care will lead to sizable demand in the market.
The report on the global oncology drugs market covers the following areas:
• Global oncology drugs market sizing
• Global oncology drugs market forecast
• Global oncology drugs market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global oncology drugs market vendors that include AbbVie Inc., Amgen Inc., AstraZeneca Plc, Bayer AG, BeiGene Ltd., Bristol Myers Squibb Co., Daiichi Sankyo Co. Ltd., Eisai Co. Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Incyte Corp., Ipsen Pharma, Johnson and Johnson, Legend Biotech Corp., MacroGenics Inc., Merck KGaA, Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi SA, Takeda Pharmaceutical Ltd.. Also, the global oncology drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

ページTOPに戻る


Table of Contents

1 Executive Summary
1.1 Market overview
• Executive Summary - Chart on Market Overview
• Executive Summary - Data Table on Market Overview
• Executive Summary - Chart on Global Market Characteristics
• Executive Summary - Chart on Market by Geography
• Executive Summary - Chart on Market Segmentation by Therapy
• Executive Summary - Chart on Market Segmentation by Distribution Channel
• Executive Summary - Chart on Market Segmentation by Form Factor
• Executive Summary - Chart on Market Segmentation by Indication
• Executive Summary - Chart on Incremental Growth
• Executive Summary - Data Table on Incremental Growth
• Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
• Chart on Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
• Chart on Overview on factors of disruption
2.4 Impact of drivers and challenges
• Chart on Impact of drivers and challenges in 2025 and 2030

3 Market Landscape
3.1 Market ecosystem
• Chart on Parent Market
• Data Table on - Parent Market
3.2 Market characteristics
• Chart on Market characteristics analysis
3.3 Value chain analysis
• Chart on Value chain analysis

4 Market Sizing
4.1 Market definition
• Data Table on Offerings of companies included in the market definition
4.2 Market segment analysis
• Market segments
4.3 Market size 2025
4.4 Market outlook: Forecast for 2025-2030
• Chart on Global - Market size and forecast 2025-2030 ($ million)
• Data Table on Global - Market size and forecast 2025-2030 ($ million)
• Chart on Global Market: Year-over-year growth 2025-2030 (%)
• Data Table on Global Market: Year-over-year growth 2025-2030 (%)

5 Historic Market Size
5.1 Global Oncology Drugs Market 2020 - 2024
• Historic Market Size - Data Table on Global Oncology Drugs Market 2020 - 2024 ($ million)
5.2 Therapy segment analysis 2020 - 2024
• Historic Market Size - Therapy Segment 2020 - 2024 ($ million)
5.3 Distribution Channel segment analysis 2020 - 2024
• Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
5.4 Form Factor segment analysis 2020 - 2024
• Historic Market Size - Form Factor Segment 2020 - 2024 ($ million)
5.5 Indication segment analysis 2020 - 2024
• Historic Market Size - Indication Segment 2020 - 2024 ($ million)
5.6 Geography segment analysis 2020 - 2024
• Historic Market Size - Geography Segment 2020 - 2024 ($ million)
5.7 Country segment analysis 2020 - 2024
• Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis
6.1 Impact of AI on global oncology drugs market
6.2 Impact of geopolitical conflicts on global oncology drugs market

7 Five Forces Analysis
7.1 Five forces summary
• Five forces analysis - Comparison between 2025 and 2030
7.2 Bargaining power of buyers
• Bargaining power of buyers - Impact of key factors 2025 and 2030
7.3 Bargaining power of suppliers
• Bargaining power of suppliers - Impact of key factors in 2025 and 2030
7.4 Threat of new entrants
• Threat of new entrants - Impact of key factors in 2025 and 2030
7.5 Threat of substitutes
• Threat of substitutes - Impact of key factors in 2025 and 2030
7.6 Threat of rivalry
• Threat of rivalry - Impact of key factors in 2025 and 2030
7.7 Market condition
• Chart on Market condition - Five forces 2025 and 2030

8 Market Segmentation by Therapy
8.1 Market segments
• Chart on Therapy - Market share 2025-2030 (%)
• Data Table on Therapy - Market share 2025-2030 (%)
8.2 Comparison by Therapy
• Chart on Comparison by Therapy
• Data Table on Comparison by Therapy
8.3 Targeted therapy - Market size and forecast 2025-2030
• Chart on Targeted therapy - Market size and forecast 2025-2030 ($ million)
• Data Table on Targeted therapy - Market size and forecast 2025-2030 ($ million)
• Chart on Targeted therapy - Year-over-year growth 2025-2030 (%)
• Data Table on Targeted therapy - Year-over-year growth 2025-2030 (%)
8.4 Immunotherapy and hormonal therapy - Market size and forecast 2025-2030
• Chart on Immunotherapy and hormonal therapy - Market size and forecast 2025-2030 ($ million)
• Data Table on Immunotherapy and hormonal therapy - Market size and forecast 2025-2030 ($ million)
• Chart on Immunotherapy and hormonal therapy - Year-over-year growth 2025-2030 (%)
• Data Table on Immunotherapy and hormonal therapy - Year-over-year growth 2025-2030 (%)
8.5 Chemotherapy - Market size and forecast 2025-2030
• Chart on Chemotherapy - Market size and forecast 2025-2030 ($ million)
• Data Table on Chemotherapy - Market size and forecast 2025-2030 ($ million)
• Chart on Chemotherapy - Year-over-year growth 2025-2030 (%)
• Data Table on Chemotherapy - Year-over-year growth 2025-2030 (%)
8.6 Market opportunity by Therapy
• Market opportunity by Therapy ($ million)
• Data Table on Market opportunity by Therapy ($ million)

9 Market Segmentation by Distribution Channel
9.1 Market segments
• Chart on Distribution Channel - Market share 2025-2030 (%)
• Data Table on Distribution Channel - Market share 2025-2030 (%)
9.2 Comparison by Distribution Channel
• Chart on Comparison by Distribution Channel
• Data Table on Comparison by Distribution Channel
9.3 Hospital pharmacies - Market size and forecast 2025-2030
• Chart on Hospital pharmacies - Market size and forecast 2025-2030 ($ million)
• Data Table on Hospital pharmacies - Market size and forecast 2025-2030 ($ million)
• Chart on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
• Data Table on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
9.4 Retail pharmacies - Market size and forecast 2025-2030
• Chart on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
• Data Table on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
• Chart on Retail pharmacies - Year-over-year growth 2025-2030 (%)
• Data Table on Retail pharmacies - Year-over-year growth 2025-2030 (%)
9.5 Online pharmacies - Market size and forecast 2025-2030
• Chart on Online pharmacies - Market size and forecast 2025-2030 ($ million)
• Data Table on Online pharmacies - Market size and forecast 2025-2030 ($ million)
• Chart on Online pharmacies - Year-over-year growth 2025-2030 (%)
• Data Table on Online pharmacies - Year-over-year growth 2025-2030 (%)
9.6 Market opportunity by Distribution Channel
• Market opportunity by Distribution Channel ($ million)
• Data Table on Market opportunity by Distribution Channel ($ million)

10 Market Segmentation by Form Factor
10.1 Market segments
• Chart on Form Factor - Market share 2025-2030 (%)
• Data Table on Form Factor - Market share 2025-2030 (%)
10.2 Comparison by Form Factor
• Chart on Comparison by Form Factor
• Data Table on Comparison by Form Factor
10.3 Solid - Market size and forecast 2025-2030
• Chart on Solid - Market size and forecast 2025-2030 ($ million)
• Data Table on Solid - Market size and forecast 2025-2030 ($ million)
• Chart on Solid - Year-over-year growth 2025-2030 (%)
• Data Table on Solid - Year-over-year growth 2025-2030 (%)
10.4 Injectable - Market size and forecast 2025-2030
• Chart on Injectable - Market size and forecast 2025-2030 ($ million)
• Data Table on Injectable - Market size and forecast 2025-2030 ($ million)
• Chart on Injectable - Year-over-year growth 2025-2030 (%)
• Data Table on Injectable - Year-over-year growth 2025-2030 (%)
10.5 Liquid - Market size and forecast 2025-2030
• Chart on Liquid - Market size and forecast 2025-2030 ($ million)
• Data Table on Liquid - Market size and forecast 2025-2030 ($ million)
• Chart on Liquid - Year-over-year growth 2025-2030 (%)
• Data Table on Liquid - Year-over-year growth 2025-2030 (%)
10.6 Market opportunity by Form Factor
• Market opportunity by Form Factor ($ million)
• Data Table on Market opportunity by Form Factor ($ million)

11 Market Segmentation by Indication
11.1 Market segments
• Chart on Indication - Market share 2025-2030 (%)
• Data Table on Indication - Market share 2025-2030 (%)
11.2 Comparison by Indication
• Chart on Comparison by Indication
• Data Table on Comparison by Indication
11.3 Blood cancer - Market size and forecast 2025-2030
• Chart on Blood cancer - Market size and forecast 2025-2030 ($ million)
• Data Table on Blood cancer - Market size and forecast 2025-2030 ($ million)
• Chart on Blood cancer - Year-over-year growth 2025-2030 (%)
• Data Table on Blood cancer - Year-over-year growth 2025-2030 (%)
11.4 Breast cancer - Market size and forecast 2025-2030
• Chart on Breast cancer - Market size and forecast 2025-2030 ($ million)
• Data Table on Breast cancer - Market size and forecast 2025-2030 ($ million)
• Chart on Breast cancer - Year-over-year growth 2025-2030 (%)
• Data Table on Breast cancer - Year-over-year growth 2025-2030 (%)
11.5 Lung cancer - Market size and forecast 2025-2030
• Chart on Lung cancer - Market size and forecast 2025-2030 ($ million)
• Data Table on Lung cancer - Market size and forecast 2025-2030 ($ million)
• Chart on Lung cancer - Year-over-year growth 2025-2030 (%)
• Data Table on Lung cancer - Year-over-year growth 2025-2030 (%)
11.6 Colorectal cancer - Market size and forecast 2025-2030
• Chart on Colorectal cancer - Market size and forecast 2025-2030 ($ million)
• Data Table on Colorectal cancer - Market size and forecast 2025-2030 ($ million)
• Chart on Colorectal cancer - Year-over-year growth 2025-2030 (%)
• Data Table on Colorectal cancer - Year-over-year growth 2025-2030 (%)
11.7 Others - Market size and forecast 2025-2030
• Chart on Others - Market size and forecast 2025-2030 ($ million)
• Data Table on Others - Market size and forecast 2025-2030 ($ million)
• Chart on Others - Year-over-year growth 2025-2030 (%)
• Data Table on Others - Year-over-year growth 2025-2030 (%)
11.8 Market opportunity by Indication
• Market opportunity by Indication ($ million)
• Data Table on Market opportunity by Indication ($ million)

12 Customer Landscape
12.1 Customer landscape overview
• Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

13 Geographic Landscape
13.1 Geographic segmentation
• Chart on Market share by geography 2025-2030 (%)
• Data Table on Market share by geography 2025-2030 (%)
13.2 Geographic comparison
• Chart on Geographic comparison
• Data Table on Geographic comparison
13.3 North America - Market size and forecast 2025-2030
• Chart on North America - Market size and forecast 2025-2030 ($ million)
• Data Table on North America - Market size and forecast 2025-2030 ($ million)
• Chart on North America - Year-over-year growth 2025-2030 (%)
• Data Table on North America - Year-over-year growth 2025-2030 (%)
• Chart on Regional Comparison - North America
• Data Table on Regional Comparison - North America
13.3.1 US - Market size and forecast 2025-2030
• Chart on US - Market size and forecast 2025-2030 ($ million)
• Data Table on US - Market size and forecast 2025-2030 ($ million)
• Chart on US - Year-over-year growth 2025-2030 (%)
• Data Table on US - Year-over-year growth 2025-2030 (%)
13.3.2 Canada - Market size and forecast 2025-2030
• Chart on Canada - Market size and forecast 2025-2030 ($ million)
• Data Table on Canada - Market size and forecast 2025-2030 ($ million)
• Chart on Canada - Year-over-year growth 2025-2030 (%)
• Data Table on Canada - Year-over-year growth 2025-2030 (%)
13.3.3 Mexico - Market size and forecast 2025-2030
• Chart on Mexico - Market size and forecast 2025-2030 ($ million)
• Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
• Chart on Mexico - Year-over-year growth 2025-2030 (%)
• Data Table on Mexico - Year-over-year growth 2025-2030 (%)
13.4 Europe - Market size and forecast 2025-2030
• Chart on Europe - Market size and forecast 2025-2030 ($ million)
• Data Table on Europe - Market size and forecast 2025-2030 ($ million)
• Chart on Europe - Year-over-year growth 2025-2030 (%)
• Data Table on Europe - Year-over-year growth 2025-2030 (%)
• Chart on Regional Comparison - Europe
• Data Table on Regional Comparison - Europe
13.4.1 Germany - Market size and forecast 2025-2030
• Chart on Germany - Market size and forecast 2025-2030 ($ million)
• Data Table on Germany - Market size and forecast 2025-2030 ($ million)
• Chart on Germany - Year-over-year growth 2025-2030 (%)
• Data Table on Germany - Year-over-year growth 2025-2030 (%)
13.4.2 France - Market size and forecast 2025-2030
• Chart on France - Market size and forecast 2025-2030 ($ million)
• Data Table on France - Market size and forecast 2025-2030 ($ million)
• Chart on France - Year-over-year growth 2025-2030 (%)
• Data Table on France - Year-over-year growth 2025-2030 (%)
13.4.3 UK - Market size and forecast 2025-2030
• Chart on UK - Market size and forecast 2025-2030 ($ million)
• Data Table on UK - Market size and forecast 2025-2030 ($ million)
• Chart on UK - Year-over-year growth 2025-2030 (%)
• Data Table on UK - Year-over-year growth 2025-2030 (%)
13.4.4 Italy - Market size and forecast 2025-2030
• Chart on Italy - Market size and forecast 2025-2030 ($ million)
• Data Table on Italy - Market size and forecast 2025-2030 ($ million)
• Chart on Italy - Year-over-year growth 2025-2030 (%)
• Data Table on Italy - Year-over-year growth 2025-2030 (%)
13.4.5 Spain - Market size and forecast 2025-2030
• Chart on Spain - Market size and forecast 2025-2030 ($ million)
• Data Table on Spain - Market size and forecast 2025-2030 ($ million)
• Chart on Spain - Year-over-year growth 2025-2030 (%)
• Data Table on Spain - Year-over-year growth 2025-2030 (%)
13.4.6 The Netherlands - Market size and forecast 2025-2030
• Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
• Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
• Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
• Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
13.5 Asia - Market size and forecast 2025-2030
• Chart on Asia - Market size and forecast 2025-2030 ($ million)
• Data Table on Asia - Market size and forecast 2025-2030 ($ million)
• Chart on Asia - Year-over-year growth 2025-2030 (%)
• Data Table on Asia - Year-over-year growth 2025-2030 (%)
• Chart on Regional Comparison - Asia
• Data Table on Regional Comparison - Asia
13.5.1 China - Market size and forecast 2025-2030
• Chart on China - Market size and forecast 2025-2030 ($ million)
• Data Table on China - Market size and forecast 2025-2030 ($ million)
• Chart on China - Year-over-year growth 2025-2030 (%)
• Data Table on China - Year-over-year growth 2025-2030 (%)
13.5.2 Japan - Market size and forecast 2025-2030
• Chart on Japan - Market size and forecast 2025-2030 ($ million)
• Data Table on Japan - Market size and forecast 2025-2030 ($ million)
• Chart on Japan - Year-over-year growth 2025-2030 (%)
• Data Table on Japan - Year-over-year growth 2025-2030 (%)
13.5.3 India - Market size and forecast 2025-2030
• Chart on India - Market size and forecast 2025-2030 ($ million)
• Data Table on India - Market size and forecast 2025-2030 ($ million)
• Chart on India - Year-over-year growth 2025-2030 (%)
• Data Table on India - Year-over-year growth 2025-2030 (%)
13.5.4 South Korea - Market size and forecast 2025-2030
• Chart on South Korea - Market size and forecast 2025-2030 ($ million)
• Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
• Chart on South Korea - Year-over-year growth 2025-2030 (%)
• Data Table on South Korea - Year-over-year growth 2025-2030 (%)
13.5.5 Taiwan - Market size and forecast 2025-2030
• Chart on Taiwan - Market size and forecast 2025-2030 ($ million)
• Data Table on Taiwan - Market size and forecast 2025-2030 ($ million)
• Chart on Taiwan - Year-over-year growth 2025-2030 (%)
• Data Table on Taiwan - Year-over-year growth 2025-2030 (%)
13.5.6 Singapore - Market size and forecast 2025-2030
• Chart on Singapore - Market size and forecast 2025-2030 ($ million)
• Data Table on Singapore - Market size and forecast 2025-2030 ($ million)
• Chart on Singapore - Year-over-year growth 2025-2030 (%)
• Data Table on Singapore - Year-over-year growth 2025-2030 (%)
13.6 Rest of World (ROW) - Market size and forecast 2025-2030
• Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
• Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
• Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
• Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
• Chart on Regional Comparison - Rest of World (ROW)
• Data Table on Regional Comparison - Rest of World (ROW)
13.6.1 Brazil - Market size and forecast 2025-2030
• Chart on Brazil - Market size and forecast 2025-2030 ($ million)
• Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
• Chart on Brazil - Year-over-year growth 2025-2030 (%)
• Data Table on Brazil - Year-over-year growth 2025-2030 (%)
13.6.2 Australia - Market size and forecast 2025-2030
• Chart on Australia - Market size and forecast 2025-2030 ($ million)
• Data Table on Australia - Market size and forecast 2025-2030 ($ million)
• Chart on Australia - Year-over-year growth 2025-2030 (%)
• Data Table on Australia - Year-over-year growth 2025-2030 (%)
13.6.3 Saudi Arabia - Market size and forecast 2025-2030
• Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
• Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
• Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
• Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
13.6.4 Argentina - Market size and forecast 2025-2030
• Chart on Argentina - Market size and forecast 2025-2030 ($ million)
• Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
• Chart on Argentina - Year-over-year growth 2025-2030 (%)
• Data Table on Argentina - Year-over-year growth 2025-2030 (%)
13.6.5 South Africa - Market size and forecast 2025-2030
• Chart on South Africa - Market size and forecast 2025-2030 ($ million)
• Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
• Chart on South Africa - Year-over-year growth 2025-2030 (%)
• Data Table on South Africa - Year-over-year growth 2025-2030 (%)
13.6.6 UAE - Market size and forecast 2025-2030
• Chart on UAE - Market size and forecast 2025-2030 ($ million)
• Data Table on UAE - Market size and forecast 2025-2030 ($ million)
• Chart on UAE - Year-over-year growth 2025-2030 (%)
• Data Table on UAE - Year-over-year growth 2025-2030 (%)
13.6.7 Chile - Market size and forecast 2025-2030
• Chart on Chile - Market size and forecast 2025-2030 ($ million)
• Data Table on Chile - Market size and forecast 2025-2030 ($ million)
• Chart on Chile - Year-over-year growth 2025-2030 (%)
• Data Table on Chile - Year-over-year growth 2025-2030 (%)
13.6.8 Turkey - Market size and forecast 2025-2030
• Chart on Turkey - Market size and forecast 2025-2030 ($ million)
• Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
• Chart on Turkey - Year-over-year growth 2025-2030 (%)
• Data Table on Turkey - Year-over-year growth 2025-2030 (%)
13.7 Market opportunity by geography
• Market opportunity by geography ($ million)
• Data Tables on Market opportunity by geography ($ million)

14 Drivers, Challenges, and Opportunity
14.1 Market drivers
• Rising prevalence of malignancies and aging demographics
• Accelerated innovation in precision medicine and novel modalities
• Expanding access and strategic clinical combinations
14.2 Market challenges
• Complexity and operational constraints in clinical trial execution
• Access barriers and stringent cost-effectiveness evaluations
• Manufacturing resilience and supply chain vulnerabilities
14.3 Impact of drivers and challenges
• Impact of drivers and challenges in 2025 and 2030
14.4 Market opportunities
• Precision medicine and biomarker-driven therapeutics
• Expansion of novel immunotherapy modalities
• Integration of AI in oncology care

15 Competitive Landscape
15.1 Overview
15.2 Competitive Landscape
• Overview on criticality of inputs and factors of differentiation
15.3 Landscape disruption
• Overview on factors of disruption
15.4 Industry risks
• Impact of key risks on business

16 Competitive Analysis
16.1 Companies profiled
• Companies covered
16.2 Company ranking index
• Company ranking index
16.3 Market positioning of companies
• Matrix on companies position and classification
16.4 AbbVie Inc.
• AbbVie Inc. - Overview
• AbbVie Inc. - Business segments
• AbbVie Inc. - Key news
• AbbVie Inc. - Key offerings
• AbbVie Inc. - Segment focus
• SWOT
16.5 Amgen Inc.
• Amgen Inc. - Overview
• Amgen Inc. - Product / Service
• Amgen Inc. - Key news
• Amgen Inc. - Key offerings
• SWOT
16.6 AstraZeneca Plc
• AstraZeneca Plc - Overview
• AstraZeneca Plc - Business segments
• AstraZeneca Plc - Key news
• AstraZeneca Plc - Key offerings
• AstraZeneca Plc - Segment focus
• SWOT
16.7 Bayer AG
• Bayer AG - Overview
• Bayer AG - Business segments
• Bayer AG - Key news
• Bayer AG - Key offerings
• Bayer AG - Segment focus
• SWOT
16.8 Bristol Myers Squibb Co.
• Bristol Myers Squibb Co. - Overview
• Bristol Myers Squibb Co. - Product / Service
• Bristol Myers Squibb Co. - Key news
• Bristol Myers Squibb Co. - Key offerings
• SWOT
16.9 Daiichi Sankyo Co. Ltd.
• Daiichi Sankyo Co. Ltd. - Overview
• Daiichi Sankyo Co. Ltd. - Business segments
• Daiichi Sankyo Co. Ltd. - Key news
• Daiichi Sankyo Co. Ltd. - Key offerings
• Daiichi Sankyo Co. Ltd. - Segment focus
• SWOT
16.10 Eli Lilly and Co.
• Eli Lilly and Co. - Overview
• Eli Lilly and Co. - Product / Service
• Eli Lilly and Co. - Key news
• Eli Lilly and Co. - Key offerings
• SWOT
16.11 F. Hoffmann La Roche Ltd.
• F. Hoffmann La Roche Ltd. - Overview
• F. Hoffmann La Roche Ltd. - Business segments
• F. Hoffmann La Roche Ltd. - Key news
• F. Hoffmann La Roche Ltd. - Key offerings
• F. Hoffmann La Roche Ltd. - Segment focus
• SWOT
16.12 GlaxoSmithKline Plc
• GlaxoSmithKline Plc - Overview
• GlaxoSmithKline Plc - Business segments
• GlaxoSmithKline Plc - Key news
• GlaxoSmithKline Plc - Key offerings
• GlaxoSmithKline Plc - Segment focus
• SWOT
16.13 Johnson and Johnson
• Johnson and Johnson - Overview
• Johnson and Johnson - Business segments
• Johnson and Johnson - Key news
• Johnson and Johnson - Key offerings
• Johnson and Johnson - Segment focus
• SWOT
16.14 Merck KGaA
• Merck KGaA - Overview
• Merck KGaA - Business segments
• Merck KGaA - Key news
• Merck KGaA - Key offerings
• Merck KGaA - Segment focus
• SWOT
16.15 Novartis AG
• Novartis AG - Overview
• Novartis AG - Business segments
• Novartis AG - Key news
• Novartis AG - Key offerings
• Novartis AG - Segment focus
• SWOT
16.16 Pfizer Inc.
• Pfizer Inc. - Overview
• Pfizer Inc. - Business segments
• Pfizer Inc. - Key news
• Pfizer Inc. - Key offerings
• Pfizer Inc. - Segment focus
• SWOT
16.17 Sanofi SA
• Sanofi SA - Overview
• Sanofi SA - Business segments
• Sanofi SA - Key news
• Sanofi SA - Key offerings
• Sanofi SA - Segment focus
• SWOT
16.18 Takeda Pharmaceutical Ltd.
• Takeda Pharmaceutical Ltd. - Overview
• Takeda Pharmaceutical Ltd. - Business segments
• Takeda Pharmaceutical Ltd. - Key news
• Takeda Pharmaceutical Ltd. - Key offerings
• Takeda Pharmaceutical Ltd. - Segment focus
• SWOT

17 Appendix
17.1 Scope of the report
• Market definition
• Objectives
• Notes and caveats
17.2 Inclusions and exclusions checklist
• Inclusions checklist
• Exclusions checklist
17.3 Currency conversion rates for US$
• Currency conversion rates for US$
17.4 Research methodology
• Research methodology
17.5 Data procurement
• Information sources
17.6 Data validation
• Data validation
17.7 Validation techniques employed for market sizing
• Validation techniques employed for market sizing
17.8 Data synthesis
• Data synthesis
17.9 360 degree market analysis
• 360 degree market analysis
17.10 List of abbreviations
• List of abbreviations

ページTOPに戻る



List of Tables/Graphs

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Market Segmentation by Form Factor
Exhibits8: Executive Summary - Chart on Market Segmentation by Indication
Exhibits9: Executive Summary - Chart on Incremental Growth
Exhibits10: Executive Summary - Data Table on Incremental Growth
Exhibits11: Executive Summary - Chart on Company Market Positioning
Exhibits12: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits13: Chart on Overview on criticality of inputs and factors of differentiation
Exhibits14: Chart on Overview on factors of disruption
Exhibits15: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibits16: Chart on Parent Market
Exhibits17: Data Table on - Parent Market
Exhibits18: Chart on Market characteristics analysis
Exhibits19: Chart on Value chain analysis
Exhibits20: Data Table on Offerings of companies included in the market definition
Exhibits21: Market segments
Exhibits22: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibits23: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibits24: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibits25: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibits26: Historic Market Size - Data Table on Global Oncology Drugs Market 2020 - 2024 ($ million)
Exhibits27: Historic Market Size - Therapy Segment 2020 - 2024 ($ million)
Exhibits28: Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
Exhibits29: Historic Market Size - Form Factor Segment 2020 - 2024 ($ million)
Exhibits30: Historic Market Size - Indication Segment 2020 - 2024 ($ million)
Exhibits31: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibits32: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibits33: Five forces analysis - Comparison between 2025 and 2030
Exhibits34: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibits35: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibits36: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibits37: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibits38: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibits39: Chart on Market condition - Five forces 2025 and 2030
Exhibits40: Chart on Therapy - Market share 2025-2030 (%)
Exhibits41: Data Table on Therapy - Market share 2025-2030 (%)
Exhibits42: Chart on Comparison by Therapy
Exhibits43: Data Table on Comparison by Therapy
Exhibits44: Chart on Targeted therapy - Market size and forecast 2025-2030 ($ million)
Exhibits45: Data Table on Targeted therapy - Market size and forecast 2025-2030 ($ million)
Exhibits46: Chart on Targeted therapy - Year-over-year growth 2025-2030 (%)
Exhibits47: Data Table on Targeted therapy - Year-over-year growth 2025-2030 (%)
Exhibits48: Chart on Immunotherapy and hormonal therapy - Market size and forecast 2025-2030 ($ million)
Exhibits49: Data Table on Immunotherapy and hormonal therapy - Market size and forecast 2025-2030 ($ million)
Exhibits50: Chart on Immunotherapy and hormonal therapy - Year-over-year growth 2025-2030 (%)
Exhibits51: Data Table on Immunotherapy and hormonal therapy - Year-over-year growth 2025-2030 (%)
Exhibits52: Chart on Chemotherapy - Market size and forecast 2025-2030 ($ million)
Exhibits53: Data Table on Chemotherapy - Market size and forecast 2025-2030 ($ million)
Exhibits54: Chart on Chemotherapy - Year-over-year growth 2025-2030 (%)
Exhibits55: Data Table on Chemotherapy - Year-over-year growth 2025-2030 (%)
Exhibits56: Market opportunity by Therapy ($ million)
Exhibits57: Data Table on Market opportunity by Therapy ($ million)
Exhibits58: Chart on Distribution Channel - Market share 2025-2030 (%)
Exhibits59: Data Table on Distribution Channel - Market share 2025-2030 (%)
Exhibits60: Chart on Comparison by Distribution Channel
Exhibits61: Data Table on Comparison by Distribution Channel
Exhibits62: Chart on Hospital pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibits63: Data Table on Hospital pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibits64: Chart on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
Exhibits65: Data Table on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
Exhibits66: Chart on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibits67: Data Table on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibits68: Chart on Retail pharmacies - Year-over-year growth 2025-2030 (%)
Exhibits69: Data Table on Retail pharmacies - Year-over-year growth 2025-2030 (%)
Exhibits70: Chart on Online pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibits71: Data Table on Online pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibits72: Chart on Online pharmacies - Year-over-year growth 2025-2030 (%)
Exhibits73: Data Table on Online pharmacies - Year-over-year growth 2025-2030 (%)
Exhibits74: Market opportunity by Distribution Channel ($ million)
Exhibits75: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits76: Chart on Form Factor - Market share 2025-2030 (%)
Exhibits77: Data Table on Form Factor - Market share 2025-2030 (%)
Exhibits78: Chart on Comparison by Form Factor
Exhibits79: Data Table on Comparison by Form Factor
Exhibits80: Chart on Solid - Market size and forecast 2025-2030 ($ million)
Exhibits81: Data Table on Solid - Market size and forecast 2025-2030 ($ million)
Exhibits82: Chart on Solid - Year-over-year growth 2025-2030 (%)
Exhibits83: Data Table on Solid - Year-over-year growth 2025-2030 (%)
Exhibits84: Chart on Injectable - Market size and forecast 2025-2030 ($ million)
Exhibits85: Data Table on Injectable - Market size and forecast 2025-2030 ($ million)
Exhibits86: Chart on Injectable - Year-over-year growth 2025-2030 (%)
Exhibits87: Data Table on Injectable - Year-over-year growth 2025-2030 (%)
Exhibits88: Chart on Liquid - Market size and forecast 2025-2030 ($ million)
Exhibits89: Data Table on Liquid - Market size and forecast 2025-2030 ($ million)
Exhibits90: Chart on Liquid - Year-over-year growth 2025-2030 (%)
Exhibits91: Data Table on Liquid - Year-over-year growth 2025-2030 (%)
Exhibits92: Market opportunity by Form Factor ($ million)
Exhibits93: Data Table on Market opportunity by Form Factor ($ million)
Exhibits94: Chart on Indication - Market share 2025-2030 (%)
Exhibits95: Data Table on Indication - Market share 2025-2030 (%)
Exhibits96: Chart on Comparison by Indication
Exhibits97: Data Table on Comparison by Indication
Exhibits98: Chart on Blood cancer - Market size and forecast 2025-2030 ($ million)
Exhibits99: Data Table on Blood cancer - Market size and forecast 2025-2030 ($ million)
Exhibits100: Chart on Blood cancer - Year-over-year growth 2025-2030 (%)
Exhibits101: Data Table on Blood cancer - Year-over-year growth 2025-2030 (%)
Exhibits102: Chart on Breast cancer - Market size and forecast 2025-2030 ($ million)
Exhibits103: Data Table on Breast cancer - Market size and forecast 2025-2030 ($ million)
Exhibits104: Chart on Breast cancer - Year-over-year growth 2025-2030 (%)
Exhibits105: Data Table on Breast cancer - Year-over-year growth 2025-2030 (%)
Exhibits106: Chart on Lung cancer - Market size and forecast 2025-2030 ($ million)
Exhibits107: Data Table on Lung cancer - Market size and forecast 2025-2030 ($ million)
Exhibits108: Chart on Lung cancer - Year-over-year growth 2025-2030 (%)
Exhibits109: Data Table on Lung cancer - Year-over-year growth 2025-2030 (%)
Exhibits110: Chart on Colorectal cancer - Market size and forecast 2025-2030 ($ million)
Exhibits111: Data Table on Colorectal cancer - Market size and forecast 2025-2030 ($ million)
Exhibits112: Chart on Colorectal cancer - Year-over-year growth 2025-2030 (%)
Exhibits113: Data Table on Colorectal cancer - Year-over-year growth 2025-2030 (%)
Exhibits114: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibits115: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibits116: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibits117: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibits118: Market opportunity by Indication ($ million)
Exhibits119: Data Table on Market opportunity by Indication ($ million)
Exhibits120: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits121: Chart on Market share by geography 2025-2030 (%)
Exhibits122: Data Table on Market share by geography 2025-2030 (%)
Exhibits123: Chart on Geographic comparison
Exhibits124: Data Table on Geographic comparison
Exhibits125: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibits126: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibits127: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibits128: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibits129: Chart on Regional Comparison - North America
Exhibits130: Data Table on Regional Comparison - North America
Exhibits131: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibits132: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibits133: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibits134: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibits135: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibits136: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibits137: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibits138: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibits139: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibits140: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibits141: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibits142: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibits143: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibits144: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibits145: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibits146: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibits147: Chart on Regional Comparison - Europe
Exhibits148: Data Table on Regional Comparison - Europe
Exhibits149: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibits150: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibits151: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibits152: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibits153: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibits154: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibits155: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibits156: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibits157: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibits158: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibits159: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibits160: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibits161: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibits162: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibits163: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibits164: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibits165: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibits166: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibits167: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibits168: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibits169: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibits170: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibits171: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibits172: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibits173: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibits174: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibits175: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibits176: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibits177: Chart on Regional Comparison - Asia
Exhibits178: Data Table on Regional Comparison - Asia
Exhibits179: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibits180: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibits181: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibits182: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibits183: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibits184: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibits185: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibits186: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibits187: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibits188: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibits189: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibits190: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibits191: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibits192: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibits193: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibits194: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibits195: Chart on Taiwan - Market size and forecast 2025-2030 ($ million)
Exhibits196: Data Table on Taiwan - Market size and forecast 2025-2030 ($ million)
Exhibits197: Chart on Taiwan - Year-over-year growth 2025-2030 (%)
Exhibits198: Data Table on Taiwan - Year-over-year growth 2025-2030 (%)
Exhibits199: Chart on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibits200: Data Table on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibits201: Chart on Singapore - Year-over-year growth 2025-2030 (%)
Exhibits202: Data Table on Singapore - Year-over-year growth 2025-2030 (%)
Exhibits203: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibits204: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibits205: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibits206: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibits207: Chart on Regional Comparison - Rest of World (ROW)
Exhibits208: Data Table on Regional Comparison - Rest of World (ROW)
Exhibits209: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibits210: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibits211: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibits212: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibits213: Chart on Australia - Market size and forecast 2025-2030 ($ million)
Exhibits214: Data Table on Australia - Market size and forecast 2025-2030 ($ million)
Exhibits215: Chart on Australia - Year-over-year growth 2025-2030 (%)
Exhibits216: Data Table on Australia - Year-over-year growth 2025-2030 (%)
Exhibits217: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibits218: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibits219: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibits220: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibits221: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibits222: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibits223: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibits224: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibits225: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibits226: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibits227: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibits228: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibits229: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibits230: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibits231: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibits232: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibits233: Chart on Chile - Market size and forecast 2025-2030 ($ million)
Exhibits234: Data Table on Chile - Market size and forecast 2025-2030 ($ million)
Exhibits235: Chart on Chile - Year-over-year growth 2025-2030 (%)
Exhibits236: Data Table on Chile - Year-over-year growth 2025-2030 (%)
Exhibits237: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibits238: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibits239: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibits240: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibits241: Market opportunity by geography ($ million)
Exhibits242: Data Tables on Market opportunity by geography ($ million)
Exhibits243: Impact of drivers and challenges in 2025 and 2030
Exhibits244: Overview on criticality of inputs and factors of differentiation
Exhibits245: Overview on factors of disruption
Exhibits246: Impact of key risks on business
Exhibits247: Companies covered
Exhibits248: Company ranking index
Exhibits249: Matrix on companies position and classification
Exhibits250: AbbVie Inc. - Overview
Exhibits251: AbbVie Inc. - Business segments
Exhibits252: AbbVie Inc. - Key news
Exhibits253: AbbVie Inc. - Key offerings
Exhibits254: AbbVie Inc. - Segment focus
Exhibits255: SWOT
Exhibits256: Amgen Inc. - Overview
Exhibits257: Amgen Inc. - Product / Service
Exhibits258: Amgen Inc. - Key news
Exhibits259: Amgen Inc. - Key offerings
Exhibits260: SWOT
Exhibits261: AstraZeneca Plc - Overview
Exhibits262: AstraZeneca Plc - Business segments
Exhibits263: AstraZeneca Plc - Key news
Exhibits264: AstraZeneca Plc - Key offerings
Exhibits265: AstraZeneca Plc - Segment focus
Exhibits266: SWOT
Exhibits267: Bayer AG - Overview
Exhibits268: Bayer AG - Business segments
Exhibits269: Bayer AG - Key news
Exhibits270: Bayer AG - Key offerings
Exhibits271: Bayer AG - Segment focus
Exhibits272: SWOT
Exhibits273: Bristol Myers Squibb Co. - Overview
Exhibits274: Bristol Myers Squibb Co. - Product / Service
Exhibits275: Bristol Myers Squibb Co. - Key news
Exhibits276: Bristol Myers Squibb Co. - Key offerings
Exhibits277: SWOT
Exhibits278: Daiichi Sankyo Co. Ltd. - Overview
Exhibits279: Daiichi Sankyo Co. Ltd. - Business segments
Exhibits280: Daiichi Sankyo Co. Ltd. - Key news
Exhibits281: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits282: Daiichi Sankyo Co. Ltd. - Segment focus
Exhibits283: SWOT
Exhibits284: Eli Lilly and Co. - Overview
Exhibits285: Eli Lilly and Co. - Product / Service
Exhibits286: Eli Lilly and Co. - Key news
Exhibits287: Eli Lilly and Co. - Key offerings
Exhibits288: SWOT
Exhibits289: F. Hoffmann La Roche Ltd. - Overview
Exhibits290: F. Hoffmann La Roche Ltd. - Business segments
Exhibits291: F. Hoffmann La Roche Ltd. - Key news
Exhibits292: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits293: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits294: SWOT
Exhibits295: GlaxoSmithKline Plc - Overview
Exhibits296: GlaxoSmithKline Plc - Business segments
Exhibits297: GlaxoSmithKline Plc - Key news
Exhibits298: GlaxoSmithKline Plc - Key offerings
Exhibits299: GlaxoSmithKline Plc - Segment focus
Exhibits300: SWOT
Exhibits301: Johnson and Johnson - Overview
Exhibits302: Johnson and Johnson - Business segments
Exhibits303: Johnson and Johnson - Key news
Exhibits304: Johnson and Johnson - Key offerings
Exhibits305: Johnson and Johnson - Segment focus
Exhibits306: SWOT
Exhibits307: Merck KGaA - Overview
Exhibits308: Merck KGaA - Business segments
Exhibits309: Merck KGaA - Key news
Exhibits310: Merck KGaA - Key offerings
Exhibits311: Merck KGaA - Segment focus
Exhibits312: SWOT
Exhibits313: Novartis AG - Overview
Exhibits314: Novartis AG - Business segments
Exhibits315: Novartis AG - Key news
Exhibits316: Novartis AG - Key offerings
Exhibits317: Novartis AG - Segment focus
Exhibits318: SWOT
Exhibits319: Pfizer Inc. - Overview
Exhibits320: Pfizer Inc. - Business segments
Exhibits321: Pfizer Inc. - Key news
Exhibits322: Pfizer Inc. - Key offerings
Exhibits323: Pfizer Inc. - Segment focus
Exhibits324: SWOT
Exhibits325: Sanofi SA - Overview
Exhibits326: Sanofi SA - Business segments
Exhibits327: Sanofi SA - Key news
Exhibits328: Sanofi SA - Key offerings
Exhibits329: Sanofi SA - Segment focus
Exhibits330: SWOT
Exhibits331: Takeda Pharmaceutical Ltd. - Overview
Exhibits332: Takeda Pharmaceutical Ltd. - Business segments
Exhibits333: Takeda Pharmaceutical Ltd. - Key news
Exhibits334: Takeda Pharmaceutical Ltd. - Key offerings
Exhibits335: Takeda Pharmaceutical Ltd. - Segment focus
Exhibits336: SWOT
Exhibits337: Inclusions checklist
Exhibits338: Exclusions checklist
Exhibits339: Currency conversion rates for US$
Exhibits340: Research methodology
Exhibits341: Information sources
Exhibits342: Data validation
Exhibits343: Validation techniques employed for market sizing
Exhibits344: Data synthesis
Exhibits345: 360 degree market analysis
Exhibits346: List of abbreviations

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同じKEY WORD(oncology)の最新刊レポート


よくあるご質問


TechNavio社はどのような調査会社ですか?


テクナビオ(TechNavio)は英国ロンドンに本社をおく幅広い市場を調査対象とする調査会社インフィニティリサーチ社(Infiniti Research)の調査レポート出版部門です。データリソースはT... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。


詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

 

2026/08/26 10:26

160.13 円

187.28 円

221.15 円

ページTOPに戻る